FrontNewsTop StoriesWorld
Trending

WHO suspends clinical trials of hydroxychloroquine for Coronavirus treatment

The World Health Organization (WHO) Director General Tedros Adhanom Ghebreyesus said on Monday that the World Health Organisation has suspended testing the malaria drug hydroxychloroquine in COVID-19 patients due to safety concerns.

Tedros said in an official statement that the executive group has implemented a temporary pause of the hydroxychloroquine arm within the Solidarity trial while the safety data is reviewed by the data safety monitoring board. He also said that the other arms of the WHO’s so-called solidarity trial,  a large international initiative to hold clinical tests of potential treatments for the virus would continue. Dr Mike Ryan added that the decision to suspend trials of hydroxychloroquine had been taken out of an abundance of caution.

Hydroxychloroquine, a drug has been endorsed by the American president Donald Trump and many other leaders as a possible treatment for the disease caused by the novel COVID-19. The US President has said he was taking the drug so as to find and implement whether the drug can be used as a medicine to prevent the infection caused by the COVID-19 pandemic.

Dr Mike Ryan added that the decision to suspend trials of hydroxychloroquine had been taken out of an abundance of caution.

NMTV

NMTV was launched in the year 1999, and is Maharashtra only accredited 24-hour, 7-day-a-week local cable news station of Navi Mumbai airing news bulletins and programs in English, Hindi and Marathi. NMTV represents the state-of-the-art in local television news coverage, delivering on a commitment of responsible and community-oriented journalism on an around-the-clock basis.

Related Articles

Back to top button
Close
Close